Elanco Animal Health Inc. (ELAN) Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi acquired 62.7147 deferred stock units in a grant or award transaction on October 16, 2026, reported at $23.5500 per unit. His reported post-transaction position was 10,025.8941 deferred stock units held directly.
Each deferred stock unit represents the right to receive one share of common stock or its cash equivalent.
Elanco Animal Health Inc President, CEO and director Jeffrey N. Simmons acquired 120.0395 deferred stock units on October 16, 2026, reported at $23.55 per unit. His directly held balance after the acquisition was 25,619.3221 deferred stock units. Each unit represents the right to receive one share of common stock or its cash equivalent; units settle following termination of employment or during a specified future year under the Executive Deferral and Stock Match Plan.
Elanco Animal Health Inc EVP and CFO Robert M. VanHimbergen acquired 8.3660 deferred stock units as an award on October 16, 2026; his reported direct balance afterward was 175.9183 units. Each unit represents the right to receive one share of common stock or its cash equivalent.
Elanco Animal Health Inc (ELAN) officer Timothy J. Bettington, Executive Vice President, Center of Strategic Growth, sold 4,350 common shares on October 15, 2026, at $23 per share. The sale was made under a Rule 10b5-1 trading plan adopted June 15, 2026. He directly held 138,911 shares following the transaction.
Elanco Animal Health Inc. officer Timothy J. Bettington reported a proposed sale of 4,350 common shares, with an approximate aggregate market value of $100,050.00. UBS Financial Services Inc. is listed as broker, and October 15, 2026 is the approximate sale date. The shares are identified as restricted stock units acquired from Elanco on April 3, 2024.
Elanco Animal Health Inc (ELAN) Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi acquired 66.7087 deferred stock units on October 2, 2026. The reported per-unit price was $22.1400, and his directly held balance following the acquisition was 9,963.1794 deferred stock units. Each unit represents the right to receive one share of common stock or its cash equivalent.
Elanco Animal Health Inc (ELAN) President, CEO and Director Jeffrey N. Simmons acquired 127.6843 deferred stock units on October 2, 2026, as a grant. His reported direct holdings after the transaction were 25,499.2826 deferred stock units. Each unit represents the right to receive one share of company common stock or its cash equivalent; units settle following termination of employment or during a specified future year under the Executive Deferral and Stock Match Plan.
Elanco Animal Health Inc. EVP and CFO Robert M. VanHimbergen acquired 8.8988 deferred stock units on October 2, 2026, at a reported price of $22.14 per unit. His directly held position was 167.5523 deferred stock units following the transaction. Each unit represents the right to receive one share of common stock or its cash equivalent.
Elanco Animal Health Inc. director Kapila K. Anand acquired 642.0277 deferred stock units on September 30, 2026, after electing to defer director cash retainer fees under the Directors' Deferral Plan. Each unit is the economic equivalent of one common share. Her reported holdings after the transaction were 10,721.5916 deferred stock units. The unit count is calculated by dividing deferred cash compensation by the $24.61 closing share price on the grant date.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that President, CEO and Director Jeffrey N. Simmons received a grant of 126.0897 Deferred Stock Units on September 18, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent and will settle after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan. Following this award, Simmons directly holds 25,371.5983 Deferred Stock Units; no Rule 10b5-1 trading plan is reported.